⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTRA News
Natera, Inc. Common Stock
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer
businesswire.com
NTRA
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post‑Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2‑ Breast Cancer
businesswire.com
NTRA
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
businesswire.com
NTRA
In Vitro Diagnostics Market Report Unveils Key Commercial Prospects
globenewswire.com
GH
NTRA
EXAS
QGEN
BDX
Natera Acquires Foresight Diagnostics
businesswire.com
NTRA
COVID-19 Diagnostic Research Report 2025: 5 Year Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides - ResearchAndMarkets.com
businesswire.com
ABT
AMGN
BDX
BIO
CERN
DGX
DHR
ENZ
EXAS
GILD
HHC
HOLX
ILMN
ISRG
JNJ
LH
LMT
MRNA
MYL
NBIX
NOC
NTRA
NVTA
ONVO
ORCL
PDD
PFE
QGEN
QRVO
REGN
RHHBY
RMD
ROST
SGEN
SIGA
SNPS
SPLK
SRPT
STEM
SYK
TCOM
TGT
TMO
TSLA
TXG
VRTX
WBA
XRAY
Employees Volunteer Over 1,500 Hours During Natera’s Annual Volunteer Month
businesswire.com
NTRA
Natera Integrates with Flatiron Health’s OncoEMR® Platform
businesswire.com
NTRA
Natera Reports Third Quarter 2025 Financial Results
businesswire.com
NTRA
Natera Announces Expansion to 20 Genes for its Fetal Focus™ Single-Gene NIPT
businesswire.com
NTRA